feed,title,long_url,short_url
SeekingAlpha,Spero Therapeutics: The Multi-Asset Pipeline Could Outpace The Tebipenem HBr Deal With GSK,https://seekingalpha.com/article/4615322,
SeekingAlpha,Cassava Sciences: Why Market Skepticism Persists Despite Positive Findings On Simufilam,https://seekingalpha.com/article/4615328,
